Lituo Biotechnology Co., Ltd is a leading hi-tech enterprise specializing in the R&D, manufacture, and distribution of high-quality in-vitro diagnostic reagents and clinical laboratory instruments. With a strong focus on cytology, Lituo develops advanced diagnostic solutions that significantly impact clinical practices.
Lituo’s cytology products, including liquid-based cytology solutions, play a crucial role in early detection and diagnosis of various diseases like cervical cancer, enhancing patient outcomes through timely and accurate results. These innovations streamline laboratory workflows, improve diagnostic accuracy, and provide healthcare professionals with reliable tools for effective disease management.
Founded in 2000, Lituo has obtained dozens of national patents, reflecting its commitment to innovation in cytology and other diagnostic areas. With a registered capital of 45 million and an annual sales turnover of approximately 100 million, Lituo continues to advance cytology diagnostics, making a global impact on healthcare.
